Foreign body infections due to Staphylococcus epidermidis

References

• Darouiche RO. Treatment of infections associated with surgical implants. New Engl J Med. 2004; 350: 1422–9
   PubMed Web of Science ®Google Scholar
• Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001; 33(suppl 2)S94–106
   PubMedGoogle Scholar
• Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. New Engl J Med. 2004; 351: 1645–54
   PubMed Web of Science ®Google Scholar
• Bengtson S. Prosthetic osteomyelitis with special reference to the knee: risks, treatment and costs. Ann Med. 1993; 25: 523–9
   PubMed Web of Science ®Google Scholar
• Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006; 81: 1159–71
   PubMed Web of Science ®Google Scholar
• Rupp ME, Archer GL. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis. 1994;19:231–43; quiz 44–5.
   Google Scholar
• Kloos WE, Bannerman TL. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev. 1994; 7: 117–40
   PubMed Web of Science ®Google Scholar
• Steckelberg JM, Osmon DR. Prosthetic joint infections. In: Bisno AL, Waldvogel FA. Infections associated with indwelling medical devices. 3rd ed. Washington, DC: American Society for Microbiology Press; 2000. p. 173–209.
   Google Scholar
• Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect. 2007; 55: 1–7
   PubMed Web of Science ®Google Scholar
• Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet. 2000; 355: 1864–8
   PubMed Web of Science ®Google Scholar
• Hugonnet S, Sax H, Eggimann P, Chevrolet JC, Pittet D. Nosocomial bloodstream infection and clinical sepsis. Emerg Infect Dis. 2004; 10: 76–81
   PubMed Web of Science ®Google Scholar
• National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990–May 1999, issued June 1999. Am J Infect Control. 1999;27:520–32.
   Google Scholar
• Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999; 27: 887–92
   PubMed Web of Science ®Google Scholar
• Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999; 29: 239–44
   PubMed Web of Science ®Google Scholar
• Hira V, Sluijter M, Estevao S, Horst-Kreft D, Ott A, de Groot R, et al. Clinical and molecular epidemiologic characteristics of coagulase-negative staphylococcal bloodstream infections in intensive care neonates. Pediatr Infect Dis J. 2007; 26: 607–12
   Google Scholar
• Thylefors JD, Harbarth S, Pittet D. Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality?. Infect Control Hosp Epidemiol. 1998; 19: 581–9
   PubMed Web of Science ®Google Scholar
• Eggimann P, Pittet D. Overview of catheter-related infections with special emphasis on prevention based on educational programs. Clin Microbiol Infect. 2002; 8: 295–309
   PubMed Web of Science ®Google Scholar
• Falcone M, Micozzi A, Pompeo ME, Baiocchi P, Fabi F, Penni A, et al. Methicillin-resistant staphylococcal bacteremia in patients with hematologic malignancies: clinical and microbiological retrospective comparative analysis of S. haemolyticus, S. epidermidis and S. aureus. J Chemother. 2004; 16: 540–8
   PubMed Web of Science ®Google Scholar
• Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol. 1999; 20: 396–401
   PubMed Web of Science ®Google Scholar
• Haas JP, Evans AM, Preston KE, Larson EL. Risk factors for surgical site infection after cardiac surgery: the role of endogenous flora. Heart Lung. 2005; 34: 108–14
   PubMedGoogle Scholar
• Whitehouse JD, Sexton D. Epidemiology and pathogenesis of and risk factors for surgical site infection. UpToDate Online. 2007;16:1 ( www.ufdol.com).
   Google Scholar
• Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis. 1998; 26: 1182–7
   PubMed Web of Science ®Google Scholar
• Petrelli D, Zampaloni C, D'Ercole S, Prenna M, Ballarini P, Ripa S, et al. Analysis of different genetic traits and their association with biofilm formation in Staphylococcus epidermidis isolates from central venous catheter infections. Eur J Clin Microbiol Infect Dis. 2006; 25: 773–81
   PubMed Web of Science ®Google Scholar
• Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, Ravel J, et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol. 2005; 187: 2426–38
   PubMed Web of Science ®Google Scholar
• Garrett DO, Jochimsen E, Murfitt K, Hill B, McAllister S, Nelson P, et al. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis. Infect Control Hosp Epidemiol. 1999; 20: 167–70
   PubMed Web of Science ®Google Scholar
• Mohanty SS, Kay PR. Infection in total joint replacements. Why we screen MRSA when MRSE is the problem?. J Bone Joint Surg. 2004; 86: 266–8
   Google Scholar
• Thore M, Kuhn I, Lofdahl S, Burman LG. Drug-resistant coagulase-negative skin staphylococci. Evaluation of four marker systems and epidemiology in an orthopaedic ward. Epidemiol Infect. 1990; 105: 95–105
   PubMedGoogle Scholar
• Galdbart JO, Morvan A, Desplaces N, el Solh N. Phenotypic and genomic variation among Staphylococcus epidermidis strains infecting joint prostheses. J Clin Microbiol. 1999; 37: 1306–12
   PubMed Web of Science ®Google Scholar
• Van Wijngaerden E, Peetermans WE, Van Lierde S, Van Eldere J. Polyclonal staphylococcus endocarditis. Clin Infect Dis. 1997; 25: 69–71
   Google Scholar
• Rijnders BJ, Van Wijngaerden E, Van Eldere J, Peetermans WE. Polyclonal Staphylococcus epidermidis intravascular catheter-related infections. Clin Microbiol Infect. 2001; 7: 388–91
   PubMedGoogle Scholar
• Vaudaux P, Kelley WL, Lew DP. Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat. Clin Infect Dis. 2006; 43: 968–70
   PubMedGoogle Scholar
• Adler H, Widmer A, Frei R. Emergence of a teicoplanin-resistant small colony variant of Staphylococcus epidermidis during vancomycin therapy. Eur J Clin Microbiol Infect Dis. 2003; 22: 746–8
   PubMed Web of Science ®Google Scholar
• Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nature Rev. 2006; 4: 295–305
   Google Scholar
• Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect. 2002; 4: 481–9
   PubMed Web of Science ®Google Scholar
• Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest. 2003; 112: 1466–77
   PubMed Web of Science ®Google Scholar
• Peters G. Pathogenesis of S epidermidis foreign body infections. Brit J Clin Prac. 1988; 57: 62–5
   Google Scholar
• Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001; 33: 1387–92
   PubMed Web of Science ®Google Scholar
• von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis. 2002; 2: 677–85
   PubMed Web of Science ®Google Scholar
• Arciola CR, Baldassarri L, Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol. 2001; 39: 2151–6
   PubMed Web of Science ®Google Scholar
• Vandecasteele SJ, Van Eldere J, Merckx R, Peetermans WE. The effect of systemic antibiotics on the microbiological diagnosis of experimental foreign body infections caused by Staphylococcus epidermidis. Diag Microbiol Infect Dis. 2004; 48: 89–95
   Google Scholar
• Lew D, Schrenzel J, Francois P, Vaudaux P. Pathogenesis, prevention, and therapy of staphylococcal prosthetic infections. Curr Clin Top Infect Dis. 2001; 21: 252–70
   Google Scholar
• Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials. 2007; 28: 1711–20
   PubMed Web of Science ®Google Scholar
• Vandecasteele SJ, Peetermans WE, Carbonez A, Van Eldere J. Metabolic activity of Staphylococcus epidermidis is high during initial and low during late experimental foreign-body infection. J Bacteriol. 2004; 186: 2236–9
   Google Scholar
• Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scot HM. Microbial biofilms. Ann Rev Microbiol. 1995; 49: 711–45
   PubMed Web of Science ®Google Scholar
• Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999; 37: 1771–6
   PubMed Web of Science ®Google Scholar
• Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis. 1990; 162: 96–102
   PubMed Web of Science ®Google Scholar
• Vadyvaloo V, Otto M. Molecular genetics of Staphylococcus epidermidis biofilms on indwelling medical devices. Int J Artif Organs. 2005; 28: 1069–78
   Google Scholar
• Mack D, Davies AP, Harris LG, Rohde H, Horstkotte MA, Knobloch JK. Microbial interactions in Staphylococcus epidermidis biofilms. Anal Bioanal Chem. 2007; 387: 399–408
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest. 1984; 73: 1191–200
   PubMed Web of Science ®Google Scholar
• Johnson GM, Lee DA, Regelmann WE, Gray ED, Peters G, Quie PG. Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun. 1986; 54: 13–20
   PubMed Web of Science ®Google Scholar
• Bernard L, Vaudaux P, Huggler E, Stern R, Frehel C, Francois P, et al. Inactivation of a subpopulation of human neutrophils by exposure to ultrahigh-molecular-weight polyethylene wear debris. FEMS Immunol Med Microbiol. 2007; 49: 425–32
   Google Scholar
• Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27:97–132; quiz 3–4; discussion 96.
   Google Scholar
• Kaiser AB, Petracek MR, Lea JW, Kernodle DS, Roach AC, Alford WC, Jr, et al. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients. Ann Surg. 1987; 206: 791–7
   PubMed Web of Science ®Google Scholar
• Widerstrom M, Monsen T, Karlsson C, Wistrom J. Molecular epidemiology of meticillin-resistant coagulase-negative staphylococci in a Swedish county hospital: evidence of intra- and interhospital clonal spread. J Hosp Infect. 2006; 64: 177–83
   PubMed Web of Science ®Google Scholar
• James PJ, Butcher IA, Gardner ER, Hamblen DL. Methicillin-resistant Staphylococcus epidermidis in infection of hip arthroplasties. J Bone Joint Surg. 1994; 76: 725–7
   Google Scholar
• Zingg W, Demartines N, Ruef C. Reduced susceptibility of coagulase-negative staphylococci in surgical patients after surgical procedures. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 16–19 December, 2005. Abstract no. K-1378; 2005.
   Google Scholar
• Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs. 2006; 66: 1089–105
   PubMed Web of Science ®Google Scholar
• Vedel G, Leruez M, Lemann F, Hraoui E, Ratovohery D. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs. Eur J Clin Microbiol Infect Dis. 1990; 9: 820–2
   PubMed Web of Science ®Google Scholar
• Sloos JH, van de Klundert JA, Dijkshoorn L, van Boven CP. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. J Antimicrob Chemother. 1998; 42: 787–91
   Google Scholar
• Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. New Engl J Med. 1992; 30: 281–6
   Google Scholar
• Mini E, Nobili S, Periti P. Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis? Drugs. 54 suppl 1997; 6: 39–52
   Google Scholar
• Cranny G, Elliott R, Weatherly H, Chambers D, Hawkins N, Myers L, , et al. A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery. Health Technol Assess. 2008;12: iii–iv, xi–xii, 1–147.
   Google Scholar
• Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001; 32: 1249–72
   PubMed Web of Science ®Google Scholar
• Eggimann P, Hugonnet S, Sax H, Harbarth S, Chevrolet JC, Pittet D. Long-term reduction of vascular access-associated bloodstream infection. Ann Intern Med. 2005; 142: 875–6
   Google Scholar
• Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. New Engl J Med. 2006; 355: 2725–32
   PubMed Web of Science ®Google Scholar
• Walder B, Pittet D, Tramer MR. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol. 2002; 23: 748–56
   PubMed Web of Science ®Google Scholar
• Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzel J, Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother. 2004; 53: 127–9
   PubMed Web of Science ®Google Scholar
• Anagnostakos K, Kelm J, Regitz T, Schmitt E, Jung W. In vitro evaluation of antibiotic release from and bacteria growth inhibition by antibiotic-loaded acrylic bone cement spacers. J Biomed Mater Res B Appl Biomater. 2005; 72: 373–8
   PubMed Web of Science ®Google Scholar
• Mandell GL. The antimicrobial activity of rifampin: emphasis on the relation to phagocytes. Rev Infect Dis 1983; 5(suppl 3)S463–7
   PubMedGoogle Scholar
• Monzon M, Oteiza C, Leiva J, Amorena B. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother. 2001; 48: 793–801
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998; 279: 1537–41
   PubMed Web of Science ®Google Scholar
• Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis. 1992; 14: 1251–3
   PubMed Web of Science ®Google Scholar
• Drancourt M, Stein A, Argenson JN, Roiron R, Groulier P, Raoult D. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother. 1997; 39: 235–40
   PubMed Web of Science ®Google Scholar
• Archer GL, Johnston JL, Vazquez GJ, Haywood HB3rd. Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. Rev Infect Dis. 1983; 5(suppl 3)S538–42
   Google Scholar
• Saginur R, Stdenis M, Ferris W, Aaron SD, Chan F, Lee C, et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother. 2006; 50: 55–61
   PubMed Web of Science ®Google Scholar
• Aslam S, Trautner BW, Ramanathan V, Darouiche RO. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother. 2007; 51: 1556–8
   PubMed Web of Science ®Google Scholar
• LaPlante KL, Mermel LA. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant. 2007; 22: 2239–46
   PubMed Web of Science ®Google Scholar
• Mogenet I, Raetz-Dillon S, Canonge JM, Archambaud M, Bonnet E. Successful treatment of Staphylococcus epidermidis hip prosthesis infection with oral linezolid. Ann Pharmacother. 2004; 38: 986–8
   Google Scholar
• Saleh-Mghir A, Ameur N, Muller-Serieys C, Ismael F, Lemaitre F, Massias L, et al. Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection. Antimicrob Agents Chemother. 2002; 46: 1122–4
   PubMedGoogle Scholar
• Isiklar ZU, Darouiche RO, Landon GC, Beck T. Efficacy of antibiotics alone for orthopaedic device related infections. Clin Orthop Relat Res. 1996; 332: 184–9
   Google Scholar
• Gagnon RF, Richards GK, Kostiner GB. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms. Adv Perit Dial. 1994; 10: 189–92
   PubMedGoogle Scholar
• Soriano A, Jurado A, Marco F, Almela M, Ortega M, Mensa J. In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis]. Rev Esp Quimioter. 2005; 18: 168–72
   Google Scholar
• Lemmen SW, Hafner H, Klik S, Lutticken R, Zolldann D. Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae. Chemotherapy. 2003; 49: 33–5
   Google Scholar
• Simon A, Bode U, Beutel K. Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clin Microbiol Infect. 2006; 12: 606–20
   PubMed Web of Science ®Google Scholar
• Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother. 2006; 50: 1865–8
   PubMed Web of Science ®Google Scholar
• Vercaigne LM, Sitar DS, Penner SB, Bernstein K, Wang GQ, Burczynski FJ. Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy. 2000; 20: 394–9
   PubMed Web of Science ®Google Scholar
• Lee JY, Ko KS, Peck KR, Oh WS, Song JH. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother. 2006; 57: 1110–5
   PubMed Web of Science ®Google Scholar
• Rubin LG, Shih S, Shende A, Karayalçin G, Lanzkowsky P. Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal. Clin Infect Dis. 1999; 29: 102–5
   PubMed Web of Science ®Google Scholar
• Yao Y, Sturdevant DE, Villaruz A, Xu L, Gao Q, Otto M. Factors characterizing Staphylococcus epidermidis invasiveness determined by comparative genomics. Infect Immun. 2005; 73: 1856–60
   PubMedGoogle Scholar
• Balaban N, Giacometti A, Cirioni O, Gov Y, Ghiselli R, Mocchegiani F, et al. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis. 2003; 187: 625–30
   PubMed Web of Science ®Google Scholar
• Nakamoto DA, Rosenfield ML, Haaga JR, Merritt K, Sachs PB, Hutton MC, et al. In vivo treatment of infected prosthetic graft material with urokinase: an animal model. J Vasc Interv Radiol. 1994; 5: 549–52
   Google Scholar
• Cerca N, Oliveira R, Azeredo J. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K. Lett Appl Microbiol. 2007; 45: 313–7
   PubMed Web of Science ®Google Scholar
• Carmen JC, Roeder BL, Nelson JL, Beckstead BL, Runyan CM, Schaalje GB, et al. Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo. J Biomater Appl. 2004; 18: 237–45
   PubMed Web of Science ®Google Scholar
• van der Borden AJ, van der Mei HC, Busscher HJ. Electric block current induced detachment from surgical stainless steel and decreased viability of Staphylococcus epidermidis. Biomaterials. 2005; 26: 6731–5
   PubMed Web of Science ®Google Scholar
• Wayne, PA. Performance standards for antimicrobial susceptibility testing. CLSI. 2007 ( www.clsi.org).
   Google Scholar
• Evans RC, Holmes CJ. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob Agents Chemother. 1987; 31: 889–94
   PubMed Web of Science ®Google Scholar
• Pascual A, Ramirez de Arellano E, Perea EJ. Activity of glycopeptides in combination with amikacin or rifampin against Staphylococcus epidermidis biofilms on plastic catheters. Eur J Clin Microbiol Infect Dis. 1994; 13: 515–7
   PubMed Web of Science ®Google Scholar
• Peck KR, Kim SW, Jung SI, Kim YS, Oh WS, Lee JY, et al. Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis. Chemotherapy. 2003; 49: 189–93
   PubMed Web of Science ®Google Scholar